Elasmogen Ltd is a next generation therapeutic biologics company discovering and developing soloMERsâ„¢ for the treatment of auto-immune mediated, inflammatory diseases. Utilising its unique soloMERâ„¢ platform, Elasmogen exploits the power of biologics as drugs but in small, simple, and stable formats that are amenable to site-specific delivery.